ABOUT BREAST CANCER

What Is Breast Cancer? Breast cancer begins with a malignant tumor that starts in the breast. A malignant tumor is a group of mutated cells that form together and invade surrounding tissues. Mutations are abnormal changes in cells. Normal cells are in our genes and usually replace themselves with healthy new ones while the old…

Read More

San Antonio Breast Cancer Symposium – A Patient Advocate’s POV

San Antonio Breast Cancer Symposium 2013

It was extremely exciting being at the 36th annual Breast Cancer Symposium in San Antonio (SABCS). I was hoping to go on Twitter during the Symposium but was having a lot of trouble during the conference with the wifi signal. I decided to concentrate on the presentations and when I could find information being reported…

Read More

Metaststatic Breast Cancer-30% for 30%-Metavivor

Campaign instructions

On October 10th, 2011 METAvivor Research and Support launched its 30% for 30% Campaign in a concerted effort to improve longevity and quality of life for persons with metastatic breast cancer (MBC). The concept is simple:  Since thirty percent of all breast cancer patients develop MBC — a fatal condition, then 30% of breast cancer research funds…

Read More

ABOUT US

About Us Advocates 4 Breast Cancer emerged from the personal journeys of patients who faced breast cancer diagnoses, intense various chemotherapies, plus local (stages 0-2), regional (stage 3) and distant (stage 4) recurrences. We wanted to learn more about our disease especially stage 4 – the one that kills. Our organization is profoundly dedicated to…

Read More

Patient Advocacy in Research: Merely an Afterthought? : The Patient: Patient-Centered Outcomes Research

help button in red

(I found this article very interesting for all of us who are patient advocates. It was written by Musa Mayer of advancedbc.org.) In 20 years of breast cancer advocacy, I’ve witnessed major changes in attitude toward advocates on the part of basic researchers, clinical investigators, and others involved with the science of the disease. Not…

Read More